We previously reported generation of keratinocytes from human iPSCs for use in the treatment of recessive dystrophic epidermolysis bullosa (RDEB) caused by mutations in the COL7A1 gene. This evidence concerns the gene COL7A1 and recessive dystrophic epidermolysis bullosa.